Document Type
Article
Publication Date
12-5-2023
Abstract
Purpose: To examine the feasibility of using MEMS® bottles to assess adherence among adolescents and emerging adults with sickle cell disease.
Patients and Methods: Eighteen non-Hispanic Black participants with HbSS (M = 17.8 years; 61% male) were given a MEMS® bottle to store hydroxyurea (n = 14) or deferasirox (n = 4).
Results: One hundred percent initiated MEMS® use and 61% sustained use through the 18-week study; at follow-up, only 11% returned their bottle on time. Barriers to MEMS® use included medication changes and transition to adult care; facilitators included tip sheets and reminders.
Conclusion: While MEMS® is acceptable to this population, ensuring sustained use and timely provision of bottles will require additional supports.
Recommended Citation
Hildenbrand, Aimee; Kidwell, Katherine; McGrady, Meghan; Mara, Constance; Quinn, Charles; and Crosby, Lori, "Feasibility of Electronic Medication Monitoring Among Adolescents and Emerging Adults with Sickle Cell Disease" (2023). Department of Pediatrics Faculty Papers. Paper 148.
https://jdc.jefferson.edu/pedsfp/148
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 3.0 License
PubMed ID
38077792
Language
English
